RMTI
Income statement / Annual
Last year (2025), Rockwell Medical Inc's total revenue was $69.26 M,
a decrease of 31.76% from the previous year.
In 2025, Rockwell Medical Inc's net income was -$5.31 M.
See Rockwell Medical Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$69.26 M |
$101.49 M |
$83.61 M |
$72.81 M |
$61.93 M |
$62.20 M |
$61.30 M |
$63.39 M |
$57.30 M |
$53.28 M |
| Cost of Revenue |
$57.56 M
|
$84.01 M
|
$74.91 M
|
$68.73 M
|
$64.35 M
|
$59.47 M
|
$58.46 M
|
$64.97 M
|
$53.60 M
|
$46.53 M
|
| Gross Profit |
$11.70 M
|
$17.48 M
|
$8.70 M
|
$4.08 M
|
-$2.42 M
|
$2.73 M
|
$2.84 M
|
-$1.58 M
|
$3.70 M
|
$6.75 M
|
| Gross Profit Ratio |
0.17
|
0.17
|
0.1
|
0.06
|
-0.04
|
0.04
|
0.05
|
-0.02
|
0.06
|
0.13
|
| Research and Development Expenses |
$0.00
|
$19.00 K
|
$1.11 M
|
$3.12 M
|
$6.84 M
|
$7.09 M
|
$6.89 M
|
$6.74 M
|
$6.32 M
|
$5.84 M
|
| General & Administrative Expenses |
$14.03 B
|
$14.11 M
|
$12.14 M
|
$15.64 M
|
$15.35 M
|
$16.18 M
|
$21.00 M
|
$22.08 M
|
$23.30 M
|
$21.12 M
|
| Selling & Marketing Expenses |
$2.35 B
|
$2.75 M
|
$2.13 M
|
$2.09 M
|
$5.73 M
|
$7.87 M
|
$9.05 M
|
$1.00 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$16.39 B
|
$16.86 M
|
$14.27 M
|
$17.74 M
|
$21.08 M
|
$24.05 M
|
$30.05 M
|
$23.08 M
|
$23.30 M
|
$21.12 M
|
| Other Expenses |
-$16.37 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$16.39 M
|
$16.88 M
|
$15.37 M
|
$20.86 M
|
$27.92 M
|
$31.15 M
|
$36.93 M
|
$29.82 M
|
$29.62 M
|
$26.96 M
|
| Cost And Expenses |
$73.95 M
|
$100.88 M
|
$90.28 M
|
$89.59 M
|
$92.27 M
|
$90.62 M
|
$95.40 M
|
$94.80 M
|
$83.22 M
|
$73.49 M
|
| Interest Income |
$234.00 K
|
$92.00 K
|
$211.00 K
|
$33.00 K
|
$22.00 K
|
$238.00 K
|
$367.08 K
|
$535.33 K
|
$790.23 K
|
$810.34 K
|
| Interest Expense |
$1.12 M
|
$1.25 M
|
$2.30 M
|
$1.94 M
|
$2.36 M
|
$1.88 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$2.19 M
|
$2.18 M
|
$1.44 M
|
$576.00 K
|
$2.52 M
|
$2.29 M
|
$2.65 M
|
$650.14 K
|
$514.36 K
|
$762.37 K
|
| EBITDA |
-$2.50 M |
$2.95 M |
-$4.69 M |
-$16.17 M |
-$27.80 M |
-$26.72 M |
-$31.48 M |
-$31.48 M |
-$25.41 M |
-$18.64 M |
| EBITDA Ratio |
-0.04
|
0.03
|
-0.06
|
-0.22
|
-0.45
|
-0.43
|
-0.51
|
-0.5
|
-0.44
|
-0.35
|
| Operating Income Ratio |
-0.07
|
0.01
|
-0.08
|
-0.23
|
-0.49
|
-0.46
|
-0.56
|
-0.51
|
-0.45
|
-0.38
|
| Total Other Income/Expenses Net |
-$623.00 K
|
-$1.09 M
|
-$1.77 M
|
-$1.90 M
|
-$2.34 M
|
-$2.47 M
|
-$3.08 M
|
-$716.70 K
|
$1.63 K
|
$810.34 K
|
| Income Before Tax |
-$5.31 M
|
-$480.00 K
|
-$8.44 M
|
-$18.68 M
|
-$32.67 M
|
-$30.89 M
|
-$37.18 M
|
-$32.13 M
|
-$25.92 M
|
-$19.40 M
|
| Income Before Tax Ratio |
-0.08
|
-0
|
-0.1
|
-0.26
|
-0.53
|
-0.5
|
-0.61
|
-0.51
|
-0.45
|
-0.36
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$3.05 M
|
$313.30 K
|
-$1.63 K
|
$404.53 K
|
| Net Income |
-$5.31 M
|
-$480.00 K
|
-$8.44 M
|
-$18.68 M
|
-$32.67 M
|
-$30.89 M
|
-$34.13 M
|
-$32.13 M
|
-$25.92 M
|
-$19.80 M
|
| Net Income Ratio |
-0.08
|
-0
|
-0.1
|
-0.26
|
-0.53
|
-0.5
|
-0.56
|
-0.51
|
-0.45
|
-0.37
|
| EPS |
-0.15 |
-0.0252 |
-0.36 |
-1.89 |
-3.83 |
-4.49 |
-5.61 |
-6.69 |
-5.61 |
-4.3 |
| EPS Diluted |
-0.15 |
-0.0252 |
-0.36 |
-1.89 |
-3.83 |
-4.49 |
-5.61 |
-6.69 |
-5.61 |
-4.29 |
| Weighted Average Shares Out |
$35.97 M
|
$31.06 M
|
$23.32 M
|
$9.87 M
|
$8.53 M
|
$6.87 M
|
$5.54 M
|
$4.80 M
|
$4.62 M
|
$4.61 M
|
| Weighted Average Shares Out Diluted |
$35.97 M
|
$31.06 M
|
$23.32 M
|
$9.87 M
|
$8.53 M
|
$6.87 M
|
$5.54 M
|
$4.80 M
|
$4.62 M
|
$4.62 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
